TO READ THIS STORY - you must have a paid subscription to Technology Review OR you can purchase special archive reading credits here. Choose from these great offers below.

I'm a paid subscriber please
log me in

I want to purchase this article for
only $1.99
(requires login)

I want to purchase five articles for
only $7.99
(requires login)

I want to buy
1 Year TOTAL Access for
only $24.95
(requires login)

Please note: Click here if you are currently a Technology Review print or digital subscriber and do not have access to this article.

December 2005

Ceasing Amniocentesis

A noninvasive test for genetic defects in fetuses has reached human clinical studies.

By Lauren Gravitz

Pregnant women seeking prenatal tests for genetic defects face difficult choices. Either they accept less-than-reliable blood tests or ultrasound interpretations that leave them anxious and guessing, or they choose amniocentesis, which punctures the embryonic sac and has a small risk of causing miscarriage.

Select from the choices above
to read the entire article.

Customer Service

Magazine Services

•	Subscription FAQ
•	Pay Your Bill
•	Renew Your Subscription
•	Change Your Address
•	Check Your Start/Expire Issue
•	Feedback
•	Buy a Back Issue
•	Permissions/Reprints
•	Cancel Your Subscription
•	Digital Subscription Customer Service